Reasons why older adults in three countries agreed with a deprescribing recommendation in a hypothetical vignette

Author:

Vordenberg Sarah E.12,Rana Ruchi1,Shang Jenny1,Choi Jae1,Scherer Aaron M.3,Weir Kristie Rebecca45ORCID

Affiliation:

1. University of Michigan College of Pharmacy Ann Arbor Michigan USA

2. University of Michigan Center for Bioethics and Social Sciences in Medicine 28000 Plymouth Rd, Ann Arbor, MI 48019 Michigan USA

3. University of Iowa Carver College of Medicine, 200 Hawkins Drive Iowa City Iowa USA

4. Sydney School of Public Health, Faculty of Medicine and Health The University of Sydney Sydney New South Wales Australia

5. Institute of Primary Health Care (BIHAM) University of Bern, Mittelstrasse 43, 3012 Bern Switzerland

Abstract

AbstractThe purpose of this study was to examine factors important to older adults who agreed with a deprescribing recommendation given by a general practitioner (GP) to a hypothetical patient experiencing polypharmacy. We conducted an online, vignette‐based, experimental study in the United Kingdom, United States and Australia with participants ≥65 years. The primary outcome was an agreement with a deprescribing recommendation (6‐point Likert scale; 1 = strongly disagree and 6 = strongly agree). We performed a content analysis of the free‐text reasons provided by participants who agreed with deprescribing (score of 5 or 6). Among 2656 participants who agreed with deprescribing, approximately 53.7% shared a preference for following the GP's recommendation or considered the GP the expert. The medication was referred to as a reason for deprescribing by 35.6% of participants. Less common themes included personal experience with medicine (4.3%) and older age (4.0%). Older adults who agreed with deprescribing in a hypothetical vignette most frequently reported a desire to follow the recommendations given the GP's expertise. Future research should be conducted to help clinicians efficiently identify patients who have a strong desire to follow the doctor's recommendations related to deprescribing, as this may allow for a tailored, brief deprescribing conversation.

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3